59 studies found for:    Open Studies | "Hypotrichosis"
Show Display Options
Rank Status Study
1 Recruiting Safety and Patient Satisfaction With GLASH VISTA™ (Bimatoprost 0.03%) in the Treatment of Eyelash Hypotrichosis in Japan
Condition: Eyelash Hypotrichosis
Intervention: Drug: Bimatoprost cutaneous solution 0.03%
2 Not yet recruiting Safety and Efficacy Study of Hairstetics' ANCHORING SYSTEM For Hair Extensions For Subjects Affected With Hair Thinning
Condition: Alopecia, Androgenetic
Intervention: Device: Hairstetics™ anchoring system
3 Not yet recruiting Adipose Tissue Derived Stem Cell Based Hair Restoration Therapy for Androgenetic Alopecia
Condition: Hair Restoration Using Autologous Mesenchymal Stem Cells
Interventions: Drug: stem cells;   Drug: platelet rich plasma
4 Recruiting Efficacy of the Use of Refrigerant Helmet to Prevent Alopecia in Patients Treated With Eribulin for Breast Cancer
Conditions: Breast Cancer;   Metastatic Breast Cancer
Intervention:
5 Recruiting Hairstetics Hair Implant Device Safety and Efficacy
Condition: Alopecia
Intervention: Device: Hairstetics hair implant device
6 Recruiting Local Pharmacokinetics and Tolerability of Bimatoprost Applied to the Scalp of Male Patients With Androgenetic Alopecia
Condition: Androgenetic Alopecia
Interventions: Drug: Bimatoprost 1% Formulation A;   Drug: Bimatoprost 1% Formulation B
7 Not yet recruiting Pharmacokinetics/ Pharmacodynamics and Safety of DA-4001 in Healthy Male Subjects With Androgenic Alopecia
Condition: Androgenic Alopecia
Interventions: Drug: DA-4001 H;   Drug: DA-4001 L
8 Not yet recruiting Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants
Conditions: Alopecia Areata;   Alopecia Totalis;   Alopecia Universalis
Intervention: Drug: Tofacitinib ointment
9 Recruiting "Impact of Chemotherapy-induced Alopecia on the Quality of Life of Women With Breast Cancer"
Condition: Chemotherapy-induced Alopecia
Intervention: Behavioral: Semi-structured interviews
10 Recruiting Investigation of FOL-005 on Clinical Safety and Effect on Hair Growth
Conditions: Hypertrichosis;   Alopecia;   Hirsutism
Interventions: Drug: FOL-005;   Other: Placebo
11 Recruiting Photosensitization Study in Androgenetic Alopecia
Condition: Androgenetic Alopecia
Interventions: Drug: Finasteride 0.25%;   Drug: Placebo for Finasteride 0.25%;   Drug: Negative Control
12 Recruiting Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Condition: Alopecia
Interventions: Drug: setipiprant;   Drug: placebo;   Drug: finasteride
13 Not yet recruiting Point-of-Care Adipose-derived Cells for Hair Growth
Condition: Androgenetic Alopecia
Interventions: Procedure: Stromal Vascular Fraction Cells (SVF Cells) Injection;   Procedure: Liposuction;   Other: Hair Measurements
14 Recruiting Topical Garlic Concentrate for Alopecia Areata in Children
Condition: Alopecia Areata
Intervention: Drug: garlic concentrate
15 Recruiting Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia Areata
Condition: Alopecia Areata
Interventions: Drug: Apremilast;   Drug: Placebo
16 Recruiting A Pilot Study of Tralokinumab in Subjects With Moderate to Severe Alopecia Areata
Condition: Alopecia Areata
Interventions: Drug: Tralokinumab;   Drug: Placebo
17 Recruiting Safety, Tolerability, and Pharmacokinetics of Bimatoprost in Men With Androgenetic Alopecia (AGA)
Conditions: Alopecia;   Alopecia, Androgenetic;   Baldness
Intervention: Drug: Bimatoprost
18 Not yet recruiting Safety and Efficacy Study of SHAPE Gel in Alopecia Areata
Condition: Alopecia Areata
Intervention: Drug: SHAPE Gel
19 Recruiting EValuation of the Impact of a TOpical Lotion on Permanent Chemotherapy Induced Hair Disorders in Cancer Survivors
Condition: Alopecia
Interventions: Other: CG428;   Other: Placebo
20 Recruiting Efficacy Study of a Cosmetic Lotion in the Treatment of Alopecia Areata in Males and Females
Condition: Alopecia Areata
Intervention: Other: MEXIS/M6S Patent - lotion against alopecia

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years